Apellis Announces Closing of Previously Announced Exchanges of Approximately $126.1 Million in Principal Amount of Its 3.500% Convertible Senior Notes Due 2026 for Common Stock

    NEXT STORY
    Sorrento Announces Positive Preliminary Results of Phase 1b Study of COVI-MSC™ for Treatment of ICU COVID-19 Patients
    PREV STORY
    Agios Announces Phase 3 ACTIVATE-T Trial of Mitapivat Achieved Primary Endpoint in Adults with Pyruvate Kinase Deficiency Who Are Regularly Transfused
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Reata Announces Promotion and New Hires For Key Leadership Roles

    author_avatar
    NASDAQ Market News

    Agios to Present at the Goldman Sachs Global Healthcare Conference on Tuesday, June 11, 2019

    author_avatar
    NASDAQ Market News

    Trinity Biotech plc to Announce Third Quarter Fiscal Year 2016 Financial Results

    DUBLIN, Ireland, Oct. 12, 2016 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), a leading ...

    author_avatar
    NASDAQ Market News